What A Day - Abortion Access In Trump’s America 2.0

Health and Human Services Secretary Robert F. Kennedy has long been a pusher of junk science, especially when it comes to research around vaccines and autism. So it should come as no surprise that he appears open to revisiting the decades-old FDA approval of the abortion drug mifepristone, at least in part based on a report from a conservative think tank that was neither peer-reviewed, nor published in a medical journal. What the report in question conveniently contradicts more than 100 peer-reviewed studies that show mifepristone is safe to use and effective. Jessica Valenti, author of book ‘Abortion: Our Bodies, Their Lives, And The Truths We Use To Win,’ joins us to talk about the state of reproductive rights in the U.S. with President Donald Trump is back in power.

And in headlines: Trump again walked back his threats for steep tariffs on the European Union, Russia unleashed another massive drone and missile attack on Ukraine, and Republican Senators throw cold water on the House version of Trump’s spending and tax plan — a.k.a. the Big Beautiful Bill.

Show Notes:

What Next | Daily News and Analysis - What Would You Pay to Stay Alive?

A Revlimid pill costs about 25 cents to make, and about a thousand dollars to buy—but it’s keeping him alive, so what choice does he have?

Guest: David Armstrong, investigates healthcare at ProPublica, author of “The Price of Remission.”

Want more What Next? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and across all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.

Podcast production by Ethan Oberman, Elena Schwartz, Paige Osburn, Anna Phillips, Madeline Ducharme, Isabel Angell, and Rob Gunther.

Learn more about your ad choices. Visit megaphone.fm/adchoices